Inhibition of phospholamban phosphorylation by O-GlcNAcylation: Implications for diabetic cardiomyopathy

Glycobiology

Volumn 20, Issue 10, 2010, Pages 1217-1226

  Yokoe, Shunichi ^a,b   Asahi, Michio ^b   Takeda, Toshihiro ^c   Otsu, Kinya ^c   Taniguchi, Naoyuki ^d   Miyoshi, Eiji ^c   Suzuki, Keiichiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

calcium signaling; cardiac function; diabetes mellitus; O linked N acetylglucosamine; phospholamban

Indexed keywords

CARBAMIC ACID DERIVATIVE; CATECHOLAMINE; HEART MUSCLE EXTRACT; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE TRANSFERASE; O (2 ACETAMIDO 2 DEOXY GLUCOPYRANOSYLIDENE)AMINO N PHENYLCARBAMATE; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE; TRANSFERASE; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; GENETIC TRANSFECTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES;

ACETYLGLUCOSAMINE; ACYLATION; ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; BLOTTING, WESTERN; CALCIUM; CALCIUM-BINDING PROTEINS; CATECHOLAMINES; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MALE; MUTAGENESIS, SITE-DIRECTED; MUTATION; MYOCYTES, CARDIAC; N-ACETYLGLUCOSAMINYLTRANSFERASES; OXIMES; PHENYLCARBAMATES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

CRICETULUS GRISEUS; RATTUS;

EID: 77956510773     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq071     Document Type: Article

References (39)

1. Arias EB, Kim J, Cartee GD. 2004. Prolonged incubation in PUGNAc results in increased protein O-linked glycosylation and insulin resistance in rat skeletal muscle. Diabetes 53:921-930.
2. Asahi M, Kimura Y, Kurzydlowski K, Tada M, MacLennan DH. 1999. Transmembrane helix M6 in sarco(endo)plasmic reticulum Ca(2+)-ATPase forms a functional interaction site with phospholamban. Evidence for physical interactions at other sites. J Biol Chem 274:32855-32862.
3. Chen YX, Du JT, Zhou LX, Liu XH, Zhao YF, Nakanishi H, Li YM. 2006. Alternative O-GlcNAcylation/O-phosphorylation of Ser16 induce different conformational disturbances to the N terminus of murine estrogen receptor beta. Chem Biol 13:937-944.
4. Choi KM, Zhong Y, Hoit BD, Grupp IL, Hahn H, Dilly KW, Guatimosim S, Lederer WJ, Matlib MA. 2002. Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283:H1398-H1408.
5. Chou TY, Hart GW, Dang CV. 1995. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270:18961-18965.
6. Clark RJ, McDonough PM, Swanson E, Trost SU, Suzuki M, Fukuda M, Dillmann WH. 2003. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 278:44230-44237.
7. Cornea RL, Jones LR, Autry JM, Thomas DD. 1997. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry 36:2960-2967.
8. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. 2001. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348.
9. Dutta K, Carmody MW, Cala SE, Davidoff AJ. 2002. Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy. JMol Cell Cardiol 34:985-996.
10. Fabiato A. 1983. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 245:C1-C14.
11. Fang B, Miller MW. 2001. Use of galactosyltransferase to assess the biological function of O-linked N-acetyl-d-glucosamine: a potential role for O-GlcNAc during cell division. Exp Cell Res 263:243-253.
12. Fulop N, Marchase RB, Chatham JC. 2007. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc Res 73:288-297.
13. Hart GW, Greis KD, Dong LY, Blomberg MA, Chou TY, Jiang MS, Roquemore EP, Snow DM, Kreppel LK, Cole RN, et al. 1995. O-linked N-acetylglucosamine: the "yin-yang" of Ser/Thr phosphorylation? Nuclear and cytoplasmic glycosylation. Adv Exp Med Biol 376:115-123.
14. Hart GW, Housley MP, Slawson C. 2007. Cycling of O-linked beta-N-acetyl-glucosamine on nucleocytoplasmic proteins. Nature 446:1017-1022.
15. Holt GD, Haltiwanger RS, Torres CR, Hart GW. 1987. Erythrocytes contain cytoplasmic glycoproteins. O-Linked GlcNAc on Band 4.1. J Biol Chem 262:14847-14850.
16. Hongo K, Kusakari Y, Kawai M, Konishi M, Kurihara S, Mochizuki S. 2002. Use of tetanus to investigate myofibrillar responsiveness to Ca(2+) in isolated mouse ventricular myocytes. Jpn J Physiol 52:121-127.
17. Hu Y, Belke D, Suarez J, Swanson E, Clark R, Hoshijima M, Dillmann WH. 2005. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ Res 96:1006-1013.
18. Kimura Y, Kurzydlowski K, Tada M, MacLennan DH. 1997. Phospholamban inhibitory function is activated by depolymerization. J Biol Chem 272: 15061-15064.
19. Lefebvre T, Alonso C, Mahboub S, Dupire MJ, Zanetta JP, Caillet-Boudin ML, Michalski JC. 1999. Effect of okadaic acid on O-linked N-acetylglucosa-mine levels in a neuroblastoma cell line. Biochim Biophys Acta 1472:71-81.
20. Luo W, Chu G, Sato Y, Zhou Z, Kadambi VJ, Kranias EG. 1998. Transgenic approaches to define the functional role of dual site phospholamban phos-phorylation. J Biol Chem 273:4734-4739.
21. Lytton J, Westlin M, Burk SE, Shull GE, MacLennan DH. 1992. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticu-lum family of calcium pumps. J Biol Chem 267:14483-14489.
22. MacLennan DH, Kranias EG. 2003. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566-577.
23. MacLennan DH, Rice WJ, Green NM. 1997. The mechanism of Ca2+ transport by sarco(endo)plasmic reticulum Ca2+-ATPases. J Biol Chem 272:28815-28818.
24. Marshall S, Bacote V, Traxinger RR. 1991. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712.
25. McClain DA. 2002. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diab Complications 16:72-80.
26. McClain DA, Lubas WA, Cooksey RC, Hazel M, Parker GJ, Love DC, Hanover JA. 2002. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99:10695-10699.
27. Misonou Y, Asahi M, Yokoe S, Miyoshi E, Taniguchi N. 2006. Acrolein produces nitric oxide through the elevation of intracellular calcium levels to induce apoptosis in human umbilical vein endothelial cells: implications for smoke angiopathy. Nitric Oxide 14:180-187.
28. Morris GL, Cheng HC, Colyer J, Wang JH. 1991. Phospholamban regulation of cardiac sarcoplasmic reticulum (Ca(2+)-Mg2+)-ATPase. Mechanism of regulation and site of monoclonal antibody interaction. J Biol Chem 266:11270-11275.
29. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, et al. 2007. The role of autophagy in car-diomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13:619-624.
30. Norby FL, Wold LE, Duan J, Hintz KK, Ren J. 2002. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 283:E658-E666.
31. Ren J, Davidoff AJ. 1997. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 272:H148-H158.
32. Sugita Y, Miyashita N, Yoda T, Ikeguchi M, Toyoshima C. 2006. Structural changes in the cytoplasmic domain of phospholamban by phospho-rylation at Ser16: a molecular dynamics study. Biochemistry 45: 11752-11761.
33. Tada M, Yamada M, Kadoma M, Inui M, Ohmori F. 1982. Calcium transport by cardiac sarcoplasmic reticulum and phosphorylation of phospholamban. Mol Cell Biochem 46:73-95.
34. Toyofuku T, Kurzydlowski K, Tada M, MacLennan DH. 1994. Amino acids Lys-Asp-Asp-Lys-Pro-Val402 in the Ca(2+)-ATPase of cardiac sarcoplasmic reticulum are critical for functional association with phospholamban. J Biol Chem 269:22929-22932.
35. Tupling R, Green H, Senisterra G, Lepock J, McKee N. 2001. Effects of 4-h ischemia and 1-h reperfusion on rat muscle sarcoplasmic reticulum function. Am J Physiol Endocrinol Metab 281:E867-E877.
36. Vosseller K, Wells L, Lane MD, Hart GW. 2002. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3 T3-L1 adipocytes. Proc Natl Acad Sci USA 99:5313-5318.
37. Wells L, Vosseller K, Hart GW. 2001. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 291:2376-2378.
38. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS, Cho JW. 2006. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8:1074-1083.
39. Zachara NE, O'Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. 2004. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 279:30133-30142.